Effects of efflux pump inhibitors on erythromycin, ciprofloxacin, and tetracycline resistance in campylobacter spp. Isolates

Microbial Drug Resistance

Volumn 18, Issue 5, 2012, Pages 492-501

  Kurinčič, Marija ^a   Klančnik, Anja ^a   Možina, Sonja Smole ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

1 (1 NAPHTHYLMETHYL)PIPERAZINE; 2 NAPHTHYLAMINE; CIPROFLOXACIN; EPIGALLOCATECHIN GALLATE; ERYTHROMYCIN; PHENYLALANINE ARGININE BETA NAPHTHYLAMIDE; PIPERAZINE; RNA 23S; TETRACYCLINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CAMPYLOBACTER COLI; CAMPYLOBACTER JEJUNI; GENE MUTATION; GENE TARGETING; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-BACTERIAL AGENTS; CAMPYLOBACTER COLI; CAMPYLOBACTER JEJUNI; CATECHIN; CIPROFLOXACIN; DIPEPTIDES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ERYTHROMYCIN; HUMANS; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; PIPERAZINES; TETRACYCLINE RESISTANCE;

BACTERIA (MICROORGANISMS); CAMPYLOBACTER; CAMPYLOBACTER COLI; CAMPYLOBACTER JEJUNI;

EID: 84866505400     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2012.0017     Document Type: Article

References (39)

1. Akiba, M., J. Lin, Y.W. Barton, and Q. Zhang. 2006. Interaction of CmeABC and CmeDEF in conferring antimicrobial resistance and maintaining cell viability in Campylobacter jejuni. J. Antimicrob. Chemother. 57:52-60. (Pubitemid 43057059)
2. Bacon, D., R. Alm, D. Burr, L. Hu, D.J. Kopecko, C.P. Ewing, T.J. Trust, and P. Guerry. 2000. Involvement of a plasmid in virulence of Campylobacter jejuni 81-176. Infect. Immun. 68:4384-4390. (Pubitemid 30497702)
3. Cagliero, C., C. Mouline, S. Payot, and A. Cloeckaert. 2005. Involvement of the CmeABC efflux pump in the macrolide resistance of Campylobacter coli. J. Antimicrob. Chemother. 56:948-950. (Pubitemid 41631924)
4. [CLSI] Clinical and Laboratory Standards Institute. 2007. Performance Standards for Antimicrobial Susceptibility Testing: Sixteenth Informational Supplement M100-S16. CLSI, Wayne, PA.
5. Corcoran, D., T. Quinn, L. Cotter, and S. Fanning. 2005. An investigation of the molecular mechanisms contributing to high-level erythromycin resistance in Campylobacter. Int. J. Antimicrob. Agents 27:40-45.
6. Dasti, J.I., U. Gross, S. Pohl, R. Lugert, M. Weig, and R. Schmidt-Ott. 2007. Role of the plasmid-encoded tet(O) gene in tetracycline-resistant clinical isolates of Campylobacter jejuni and Campylobacter coli. J. Med. Microbiol. 56: 833-837. (Pubitemid 46911241)
7. de Jong, A., R. Bywater, P. Butty, E. Deroover, K. Godinho, U. Klein, H. Marion, S. Simjee, K. Smets, V. Thomas, M. Vallè , and A. Wheadon. 2009. A pan-European survey of antimicrobial susceptibility towards human-use antimicrobial drugs among zoonotic and commensal enteric bacteria isolated from healthy food-producing animals. J. Antimicrob. Chemother. 63:733-744.
8. European Food Safety Authority (EFSA). 2011. European Union Summary Report on Trends and Sources of Zoonoses, Zoonotic Agents and Food-borne Outbreaks in 2009. EFSA J. 9:2090. Available at: www.efsa.europa.eu/en/ efsajournal/pub/2090.htm
9. Garvey, M.I., M.M. Rahman, S. Gibbons, and L.J. Piddock. 2011. Medicinal plant extracts with efflux inhibitory activity against Gram-negative bacteria. Int. J. Antimicrob. Agents 37:145-151.
10. Gibreel, A., V.N. Kos, M. Keelan, C.A. Trieber, S. Levesque, S. Michaud, and D.E. Taylor. 2005. Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype. Antimicrob. Agents Chemother. 49:2753-2759. (Pubitemid 40917588)
11. Gibreel, A., N.M. Wetsch, and D.E. Taylor. 2007. Contribution of the CmeABC efflux pump to macrolide and tetracycline resistance in Campylobacter jejuni. Antimicrob. Agents Chemother. 51:3212-3216. (Pubitemid 350067530)
12. Guo, B., J. Lin, D.L. Reynolds, and Q. Zhang. 2010. Contribution of the multidrug efflux transporter CmeABC to antibiotic resistance in different Campylobacter species. Foodborne Pathog. Dis. 7:77-83.
13. Hannula, M., and M.L. Hänninen. 2008. Effect of putative efflux pump inhibitors and inducers on the antimicrobial susceptibility of Campylobacter jejuni and Campylobacter coli. J. Med. Microbiol. 57:851-855.
14. Jankun, J., S.H. Selman, R. Swiercz, and E. Skrzypczak-Jankun. 1997. Why drinking green tea could prevent cancer. Nature 387:561. (Pubitemid 27248750)
15. Jeon, B., Y. Wang, H. Hao, Y.W. Barton, and Q. Zhang. 2011. Contribution of CmeG to antibiotic and oxidative stress resistance in Campylobacter jejuni. J. Antimicrob. Chemother. 66:79-85.
16. Kern, W.V., P. Steinke, P. Schumacher., S. Schuster, H. von Baum, and J.A. Bohnert. 2006. Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli. J. Antimicrob. Chemother. 57:339-343. (Pubitemid 43160180)
17. Klancnik, A., B. Guzej, M. Hadolin Kolar, H. Abramovic, and S. Smole Mozina. 2009. In vitro antimicrobial and antioxidant activity of commercial rosemary extract formulations. J. Food Protect. 72:1744-1752.
18. Kurincic M, I. Berce, T. Zorman, and S. Smole Mozina. 2005. The prevalence of multiple antibiotic resistance in Campylobacter spp. from retail poultry meat. Food Technol. Biotechnol. 43:157-163. (Pubitemid 40749981)
19. Kurincic, M., N. Botteldoorn, L. Herman, and S. Smole Mozina. 2007. Mechanisms of erythromycin resistance of Campylobacter spp. isolated from food, animals and humans. Int. J. Food Microbiol. 120:186-190. (Pubitemid 350051497)
20. Lin, J., L.O. Michel, and Q. Zhang. 2002. CmeABC functions as a multidrug efflux system in Campylobacter jejuni. Antimicrob. Agents Chemother. 46:2124-2131. (Pubitemid 34665906)
21. Lin, J., M. Akiba, O. Sahin, and Q. Zhang. 2005. CmeR functions as a transcriptional repressor for the multidrug efflux pump CmeABC in Campylobacter jejuni. Antimicrob. Agents Chemother. 49:1067-1075. (Pubitemid 40327725)
22. Lomovskaya, O., M.S. Warren, A. Lee, J. Galazzo, R. Fronko, M. Lee, J. Blais, D. Cho, S. Chamberland, T. Renau, R. Leger, S. Hecker, W. Watkins, K. Hoshino, H. Ishida, and V.J. Lee. 2001. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob. Agents Chemother. 45:105-116. (Pubitemid 32039101)
23. Luangtongkum, T., B. Jeon, J. Han, P. Plummer, C.M Logue, and Q. Zhang. 2009. Antibiotic resistance in Campylobacter: emergence, transmission and persistence. Future Microbiol. 4:189-200.
24. Mahamoud, A., J. Chevalier, S. Alibert-Franco, W.V. Kern, and J.-M. Pagès. 2007. Antibiotic efflux pumps in Gramnegative bacteria: the inhibitor response strategy. J. Antimicrob. Chemother. 59:1223-1229. (Pubitemid 47073340)
25. Martinez, A., and J. Lin. 2006. Effect of an efflux pump inhibitor on the function of the multidrug efflux pump CmeABC and antimicrobial resistance in Campylobacter. Foodborne Pathog. Dis. 3:393-402. (Pubitemid 46106315)
26. Moore, J.E., M.D. Barton, J.S. Blair, D. Corcoran, J.S. Dooley, S. Fanning, I. Kempf, A.J. Lastovica, C.J. Lowery, M. Matsuda, D.A. McDowell, A. McMahon, B.C. Millar, J.R. Rao, P.J. Rooney, B.S. Seal, W.J. Snelling, and O. Tolba. 2006. The epidemiology of antibiotic resistance in Campylobacter. Microbes Infect. 8:1955-1966. (Pubitemid 44137501)
27. Palaniappan, K., and R.H. Holley. 2010. Use of natural antimicrobials to increase antibiotic susceptibility of drug resistant bacteria. Int. J. Food Microbiol. 140:164-168.
28. Payot, S., L. Avrain, C. Magras, K. Praud, A. Cloeckaert, and E. Chaslus-Dancla. 2004. Relative contribution of target gene mutation and efflux to fluoroquinolone and erythromycin resistance, in French poultry and pig isolates of Campylobacter coli. Int. J. Antimicrob. Agents 23:468-472. (Pubitemid 38569595)
29. Piddock, L.J., V. Ricci, L. Pumbwe, M.J. Everett, and D.J Griggs. 2003. Fluoroquinolone resistance in Campylobacter species from man and animals: detections of mutations in topoisomerase genes. J. Antimicrob. Chemother. 51:19-26. (Pubitemid 36163823)
30. Piddock, L.J. 2006. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin. Microbiol. Rev. 19:382-402.
31. Piddock, L.J. 2010. Natural and synthetic compounds such as trimethoprim behave as inhibitors of efflux in Gram-negative bacteria. J. Antimicrob. Chemother. 65:1215-1223.
32. Roccaro, A.S., A.R. Blanco, F. Giuliano, D. Rusciano, and V. Enea. 2004. Epigallocatechin-gallate enhances the activity of tetracycline in staphylococci by inhibiting its efflux from bacterial cells. Antimicrob. Agents Chemother. 48:1968-1973. (Pubitemid 38691584)
33. Sonnet, P., D. Izard, and C. Mullié. 2012. Prevalence of efflux-mediated ciprofloxacin and levofloxacin resistance in recent clinical isolates of Pseudomonas aeruginosa and its reversal by the efflux pump inhibitors 1-(1-naphthylmethyl)-piperazine and phenylalanine-arginine-β- naphthylamide. Int. J. Antimicrob. Agents 39:77-80.
34. Stavri, M., L.J. Piddock, and S. Gibbons. 2007. Bacterial efflux pump inhibitors from natural sources. J. Antimicrob. Chemother. 59:1247-1260. (Pubitemid 47073343)
35. Taylor, D.E., and A. Chau. 1996. Tetracycline resistance mediated by ribosomal protection. Antimicrob. Agents Chemother. 40:1-5. (Pubitemid 26019668)
36. Tegos, G.P., M. Haynes, J.J. Strouse, M.M. Khan, C.G. Bologa, T.I. Oprea, and L.A. Sklar. 2011. Microbial efflux pump inhibition: tactics and strategies. Curr. Pharm. Des. 17:1291-1302.
37. Wang, Y., and D.E. Taylor. 1990. Natural transformation in Campylobacter Species. J. Bacteriol. 172:949-955. (Pubitemid 20070406)
38. Westrell, T., N. Ciampa, F. Boelaert, B. Helwigh, H. Korsgaard, M. Chríel, A. Ammon, and P. Mäkelä. 2009. Zoonotic infections in Europe in 2007: a summary of the EFSA-ECDC Annual Report. Eurosurveillance 14:1-3.
39. Zorman, T., and S. Smole Mozina. 2002. Classical and molecular identification of thermotolerant campylobacters from poultry meat. Food Technol. Biotechnol. 40:177-183.